Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network
Authors:
- Bettina BankampBBBettina Bankamp
- Raydel AndersonRARaydel Anderson
- Lijuan HaoLHLijuan Hao
- Elena LoparevaELElena Lopareva
- Min-Hsin ChenMCMin-Hsin Chen
- Gimin KimGKGimin Kim
- R. Suzanne BeardRBR. Suzanne Beard
- Yoshio MoriYMYoshio Mori
- Noriyuki OtsukiNONoriyuki Otsuki
- Akihido RyoARAkihido Ryo
- Paul A. RotaPRPaul A. Rota
Open Access
Abstract
More than 100 laboratories in the World Health Organization Global Measles and Rubella Laboratory Network (GMRLN) perform nucleic acid-based methods for case confirmation of measles or rubella infections and/or strain surveillance (genotyping). The quality of laboratory data is critical to ensure that diagnostic results and country reports to regional verification committees are based on accurate data. A molecular External Quality Assurance (mEQA) program was initiated by the US-CDC in 2014 to evaluate the performance of laboratories in the network. The inclusion of testing for measles and rubella viruses, with a focus on detection and genotyping, plus the diversity of assays and platforms employed required a flexible and comprehensive proficiency testing program. A stepwise introduction of new evaluation criteria gradually increased the stringency of the proficiency testing program, while giving laboratories time to implement the required changes. The mEQA program plays an important role in many processes in the GMRLN, including informing plans for the training of laboratory staff, access to reagents, and the submission of sequence data to global databases. The EQA program for Local Public Health Institutes in Japan is described as an example for national mEQA programs. As more laboratories initiate molecular testing, the mEQA will need to continue to expand and to adapt to the changing landscape for molecular testing.Keywords
This publication has 18 references indexed in Scilit:
- Progress Toward Measles Elimination — Worldwide, 2000–2022MMWR. Morbidity and Mortality Weekly Report, 2023
- Optimisation of methodology for whole genome sequencing of Measles Virus directly from patient specimensJournal of Virological Methods, 2022
- Fifteen years of the proficiency testing program for HIV-1 viral load testing laboratories in China, 2005-2019Journal of Clinical Virology, 2021
- Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCRClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficienciesPLOS Pathogens, 2019
- Analysis of complete genomes of the rubella virus genotypes 1E and 2B which circulated in China, 2000–2013Scientific Reports, 2016
- Assessment of the Utility of Whole Genome Sequencing of Measles Virus in the Characterisation of OutbreaksPLOS ONE, 2015
- Whole-Genome Sequencing of Measles Virus Genotypes H1 and D8 During Outbreaks of Infection Following the 2010 Olympic Winter Games Reveals Viral Transmission RoutesThe Journal of Infectious Diseases, 2015
- Improving molecular tools for global surveillance of measles virusJournal of Clinical Virology, 2013
- Analysis of whole genome sequences of 16 strains of rubella virus from the United States, 1961–2009Virology Journal, 2013